PLAQUE PSORIASIS
Clinical trials for PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug boost psoriasis treatment in overweight patients?
Disease control Not yet recruitingThis study tests whether adding metformin (a diabetes drug) to the standard psoriasis treatment secukinumab works better than secukinumab alone for overweight or obese Chinese patients with moderate-to-severe plaque psoriasis. About 186 participants will be randomly assigned to r…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Psoriasis drug combo aims to tackle skin and cholesterol in one shot
Disease control Not yet recruitingThis phase 4 trial tests whether adding recaticimab to vunakizumab works better than vunakizumab alone for adults with moderate-to-severe plaque psoriasis and high cholesterol. Forty participants will be randomly assigned to receive either the drug combo or vunakizumab plus a pla…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New psoriasis pill enters Mid-Stage trial
Disease control Not yet recruitingThis phase 2 trial tests an oral tablet called HSK47388 in 220 adults with moderate-to-severe plaque psoriasis. Participants take the drug or a placebo once daily for 16 weeks. The main goal is to see if the drug can reduce psoriasis severity by at least 75% compared to placebo.
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:49 UTC
-
Immune cell clues may unlock better HS treatment
Knowledge-focused Not yet recruitingThis study looks at how certain immune cells, called MAIT cells, behave in people with hidradenitis suppurativa (HS), a painful skin condition. Researchers will take skin and blood samples from 45 adults with HS and compare them to samples from people with other skin diseases. Th…
Matched conditions: PLAQUE PSORIASIS
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC